These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32367839)

  • 1. Clinical profile of lung cancer in North India: A 10-year analysis of 1862 patients from a tertiary care center.
    Mohan A; Garg A; Gupta A; Sahu S; Choudhari C; Vashistha V; Ansari A; Pandey R; Bhalla AS; Madan K; Hadda V; Iyer H; Jain D; Kumar R; Mittal S; Tiwari P; Pandey RM; Guleria R
    Lung India; 2020; 37(3):190-197. PubMed ID: 32367839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct clinical features and outcomes in never-smokers with nonsmall cell lung cancer who harbor EGFR or KRAS mutations or ALK rearrangement.
    Kim HR; Shim HS; Chung JH; Lee YJ; Hong YK; Rha SY; Kim SH; Ha SJ; Kim SK; Chung KY; Soo R; Kim JH; Cho BC
    Cancer; 2012 Feb; 118(3):729-39. PubMed ID: 21720997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics associated with ALK rearrangements in never-smokers with pulmonary adenocarcinoma.
    Sun JM; Lira M; Pandya K; Choi YL; Ahn JS; Mao M; Han J; Park K; Ahn MJ; Kim J
    Lung Cancer; 2014 Feb; 83(2):259-64. PubMed ID: 24300132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Driver genes expression and clinical characteristics of targeted therapy in non-small cell lung cancer in Yunnan-Kweichow Plateau].
    Lin YP; Li Q; Ma LY; Liu X; Dai M; Wang XX; Li HS; Liu JX; Shen ZH; Guo YJ; Du YX; Yang RJ; Huang YC; Zhou YC
    Zhonghua Zhong Liu Za Zhi; 2020 Sep; 42(9):735-740. PubMed ID: 32988155
    [No Abstract]   [Full Text] [Related]  

  • 5. Current Smoking has a Detrimental Effect on Survival for Epidermal Growth Factor Receptor (EGFR) and Anaplastic Lymphoma Kinase (ALK) negative Advanced non-squamous Non-small Cell Lung Cancer (NSCLC) Patients Treated with Pemetrexed Continuation Maintenance.
    Lin L; Zhao J; Hu J; Zou G; Huang F; Han J; He Y; Cao X
    J Cancer; 2018; 9(12):2140-2146. PubMed ID: 29937933
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidermal growth factor receptor and anaplastic lymphoma kinase testing and mutation prevalence in patients with advanced non-small cell lung cancer in Switzerland: A comprehensive evaluation of real world practices.
    Ess SM; Herrmann C; Frick H; Krapf M; Cerny T; Jochum W; Früh M
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28557060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world treatment patterns and survival outcomes for advanced non-small cell lung cancer in the pre-immunotherapy era in Portugal: a retrospective analysis from the I-O Optimise initiative.
    Soares M; Antunes L; Redondo P; Borges M; Hermans R; Patel D; Grimson F; Munro R; Chaib C; Lacoin L; Daumont M; Penrod JR; O'Donnell JC; Bento MJ; Rocha Gonçalves F
    BMC Pulm Med; 2020 Sep; 20(1):240. PubMed ID: 32912174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Environmental Tobacco Smoke Exposure and the Occurrence of EGFR Mutations and ALK Rearrangements in Never-smokers With Non-Small-cell Lung Cancer: Analyses From a Prospective Multinational ETS Registry.
    Soo RA; Kubo A; Ando M; Kawaguchi T; Ahn MJ; Ou SI
    Clin Lung Cancer; 2017 Sep; 18(5):535-542. PubMed ID: 28433570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Targeted DNA Sequencing in Advanced Non-Small-Cell Lung Cancer Patients Without EGFR and ALK Alterations on Conventional Tests.
    Byeon S; Lee B; Park WY; Choi YL; Jung HA; Sun JM; Ahn JS; Ahn MJ; Park K; Lee SH
    Clin Lung Cancer; 2020 May; 21(3):e182-e190. PubMed ID: 31839532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insights into anaplastic lymphoma kinase-positive nonsmall cell lung cancer.
    Dubey AP; Pathi N; Viswanath S; Rathore A; Pathak A; Sud R
    Indian J Cancer; 2017; 54(1):203-208. PubMed ID: 29199691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evolving epidemiology of lung cancer in India: Reducing non-small cell lung cancer-not otherwise specified and quantifying tobacco smoke exposure are the key.
    Kaur H; Sehgal IS; Bal A; Gupta N; Behera D; Das A; Singh N
    Indian J Cancer; 2017; 54(1):285-290. PubMed ID: 29199707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real-world practice patterns for patients with advanced non-small cell lung cancer: multicenter retrospective cohort study in Japan.
    Isobe H; Mori K; Minato K; Katsura H; Taniguchi K; Arunachalam A; Kothari S; Cao X; Kato T
    Lung Cancer (Auckl); 2017; 8():191-206. PubMed ID: 29123433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis.
    Rodriguez EF; VandenBussche CJ; Chowsilpa S; Maleki Z
    Cancer Cytopathol; 2018 Oct; 126(10):853-859. PubMed ID: 30199148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of cytology based molecular analysis to guide targeted therapy in advanced non-small-cell lung cancer.
    Li W; Zhang Z; Guo L; Qiu T; Ling Y; Cao J; Guo H; Zhao H; Li L; Ying J
    Oncotarget; 2016 Feb; 7(7):8332-40. PubMed ID: 26789109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
    de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
    Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing incidence of adenocarcinoma lung in India: Following the global trend?
    Mohan A; Latifi AN; Guleria R
    Indian J Cancer; 2016; 53(1):92-5. PubMed ID: 27146752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR mutations and ROS1 and ALK rearrangements in a large series of non-small cell lung cancer in South India.
    Tarigopula A; Ramasubban G; Chandrashekar V; Govindasami P; Chandran C
    Cancer Rep (Hoboken); 2020 Dec; 3(6):e1288. PubMed ID: 32881404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic implications of ALK and ROS1 rearrangements in never-smokers with surgically resected lung adenocarcinoma.
    Kim MH; Shim HS; Kang DR; Jung JY; Lee CY; Kim DJ; Lee JG; Bae MK; Kim HR; Lim SM; Kim EY; Park JS; Chung KY; Kim HJ; Kim JH; Cho BC
    Lung Cancer; 2014 Mar; 83(3):389-95. PubMed ID: 24462463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of research and treatment for non-small cell lung cancer in never-smoking females.
    Saito S; Espinoza-Mercado F; Liu H; Sata N; Cui X; Soukiasian HJ
    Cancer Biol Ther; 2017 Jun; 18(6):359-368. PubMed ID: 28494184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features.
    Yano T; Haro A; Shikada Y; Maruyama R; Maehara Y
    Int J Clin Oncol; 2011 Aug; 16(4):287-93. PubMed ID: 21562939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.